Oleamide potentiates benzodiazepine-sensitive gamma-aminobutyric acid receptor activity but does not alter minimum alveolar anesthetic concentration.

作者: C. Spencer Yost , Aidan J. Hampson , Dmitri Leonoudakis , Donald D. Koblin , Lester M. Bornheim

DOI: 10.1097/00000539-199806000-00031

关键词:

摘要: UNLABELLED A naturally occurring brain lipid, cis-9,10-octadeceamide--oleamide (OA), is found in increased concentrations the cerebrospinal fluid of sleep-deprived cats, which suggests that it may be an endogenous sleep-inducing substance. We studied effects this fatty-acid derivative on function cloned gamma-aminobutyric acid (GABA(A)) receptors expressed Xenopus oocytes. Oocytes were injected with cRNA synthesized vitro to express simple GABA(A) (alpha1beta1, alpha3beta1, alpha5beta1, and alpha1beta2 subunit combinations) GABA-induced chloride currents potentiated presence benzodiazepines (alpha1beta1gamma2s alpha1beta2gamma2s combinations). OA only produced significant potentiation peak Cl- current when applied GABA benzodiazepine-sensitive receptors. The either unaffected or slightly inhibited by OA, but overall mean not significantly altered. Oleic was also capable potentiating receptor function. other ligand-gated ion channels, such as N-methyl-D-aspartate (NR1 + NR2A 2C) 5-HT3 oocytes, OA. Sprague-Dawley rats receiving intraperitoneal injections oleamide (10, 20, 100 mg/kg) showed no change minimum alveolar anesthetic concentration (MAC) desflurane required abolish movement response noxious (tail clamp) stimulation (control MAC 6.48% +/- 1.28% atm; mg/kg 7.05% 0.42% atm). These results reinforce view oleyl compounds natural modulators inhibitory channel function, these contribute little central nervous system depression volatile anesthetics measured MAC. IMPLICATIONS putative substance, oleamide, potentiates does alter rats.

参考文章(21)
Raphael Mechoulam, Ester Fride, Lumir Hanu, Tzviel Sheskin, Tiziana Bisogno, Vincenzo Di Marzo, Michael Bayewitch, Zvi Vogel, Anandamide may mediate sleep induction Nature. ,vol. 389, pp. 25- 26 ,(1997) , 10.1038/37891
R. A. Nicoll, R. C. Malenka, J. A. Kauer, Functional comparison of neurotransmitter receptor subtypes in mammalian central nervous system Physiological Reviews. ,vol. 70, pp. 513- 565 ,(1990) , 10.1152/PHYSREV.1990.70.2.513
Benjamin F. Cravatt, Dan K. Giang, Stephen P. Mayfield, Dale L. Boger, Richard A. Lerner, Norton B. Gilula, Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides Nature. ,vol. 384, pp. 83- 87 ,(1996) , 10.1038/384083A0
Dolan B. Pritchett, Harald Sontheimer, Brenda D. Shivers, Sanie Ymer, Helmut Kettenmann, Peter R. Schofield, Peter H. Seeburg, Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology. Nature. ,vol. 338, pp. 582- 585 ,(1989) , 10.1038/338582A0
Max Willow, Graham A. R. Johnston, Dual Action of Pentobarbitone on GABA Binding: Role of Binding Site Integrity Journal of Neurochemistry. ,vol. 37, pp. 1291- 1294 ,(1981) , 10.1111/J.1471-4159.1981.TB04680.X
Michel Khrestchatisky, A.John MacLennan, Ming-Yi Chiang, Wentao Xu, Meyer B. Jackson, Nicholas Brecha, Catia Sternini, Richard W. Olsen, Allan J. Tobin, A novel α subunit in rat brain GABAA receptors Neuron. ,vol. 3, pp. 745- 753 ,(1989) , 10.1016/0896-6273(89)90243-2
Jean-Marc Fritschy, Hanns Mohler, GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. The Journal of Comparative Neurology. ,vol. 359, pp. 154- 194 ,(1995) , 10.1002/CNE.903590111